Crescita Therapeutics (TSX:CTX) Receivables Turnover : 2.18 (As of Sep. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Crescita Therapeutics Receivables Turnover?

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Crescita Therapeutics's Revenue for the three months ended in Sep. 2024 was C$3.59 Mil. Crescita Therapeutics's average Accounts Receivable for the three months ended in Sep. 2024 was C$1.65 Mil. Hence, Crescita Therapeutics's Receivables Turnover for the three months ended in Sep. 2024 was 2.18.

Crescita Therapeutics Receivables Turnover Historical Data

The historical data trend for Crescita Therapeutics's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Crescita Therapeutics Receivables Turnover Chart

Crescita Therapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Receivables Turnover

Get a 7-Day Free Trial

5.94

8.92

10.55

7.06

6.09

Crescita Therapeutics Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Receivables Turnover	Get a 7-Day Free Trial															1.01	2.69	2.15	1.45	2.18

Competitive Comparison of Crescita Therapeutics's Receivables Turnover

For the Drug Manufacturers - Specialty & Generic subindustry, Crescita Therapeutics's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Crescita Therapeutics's Receivables Turnover Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Crescita Therapeutics's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Crescita Therapeutics's Receivables Turnover falls into.

Crescita Therapeutics Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Crescita Therapeutics's Receivables Turnover for the fiscal year that ended in Dec. 2023 is calculated as

	Receivables Turnover (A: Dec. 2023 )
=	Revenue	/	Average Total Inventories
=	Revenue (A: Dec. 2023 )	/ (	(Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )
=	17.522	/ (	(4.561	+	1.19)	/	2 )
=	17.522	/	2.8755
=	6.09

Crescita Therapeutics's Receivables Turnover for the quarter that ended in Sep. 2024 is calculated as

	Receivables Turnover (Q: Sep. 2024 )
=	Revenue	/	Average Total Inventories
=	Revenue (Q: Sep. 2024 )	/ (	(Accounts Receivable (Q: Jun. 2024 )	+	Accounts Receivable (Q: Sep. 2024 ))	/	count )
=	3.594	/ (	(2.191	+	1.102)	/	2 )
=	3.594	/	1.6465
=	2.18

Crescita Therapeutics (TSX:CTX) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.

Crescita Therapeutics Receivables Turnover Related Terms

Thank you for viewing the detailed overview of Crescita Therapeutics's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.

Crescita Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Crescita Therapeutics Inc (TSX:CTX) » Definitions » Receivables Turnover

Comparable Companies

Traded in Other Exchanges

CRRTF:USA

Address

2805, Place Louis-R-Renaud, Laval, QC, CAN, H7V 0A3

Website

https://www.crescitatherapeutics.com

Crescita Therapeutics Inc is a Canadian commercial dermatology company with in-house research & development and manufacturing capabilities. The company offers a portfolio of non-prescription skincare products and early to commercial-stage prescription drug products and owns multiple proprietary drug delivery platforms that support the development of patented formulations that can facilitate the delivery of active ingredients into or through the skin. The company has three reportable segments: Commercial Skincare, Licensing and Royalties, and Manufacturing and Services. The firm generates its revenue from Commercial Skincare Product Sales in Canada.

Executives

Daniel Chicoine	Director, Senior Officer
Jose Darocha	Director, Senior Officer
Serge Verreault	Senior Officer
Anthony Edward Dobranowski	Director
Knight Therapeutics Inc.	10% Security Holder

Crescita Therapeutics Headlines

No Headlines